在单胺代谢,神经发育和神经退行中DNAJC12
Isaac Bul Deng1, Jordan Follett1, Mengfei Bu1
1Department of Neurology, University of Florida, Gainesville, Florida, USA.
Movement disorders : official journal of the Movement Disorder Society
|November 28, 2023
概括
DNAJC12中的致病变体可以导致神经系统疾病. 本综述强调了基因型-表型相关性和DNAJC12相关疾病的治疗方法,强调了早期诊断和干预.
科学领域:
- 遗传学 是一个遗传学.
- 神经学 神经学
- 生物化学 生物化学
背景情况:
- DNAJC12中的致病变体,是单胺合成的辅助者,与神经疾病有关.
- 这些疾病包括轻度的超氨酸血症,婴儿性 dystonia,帕金森症,发育迟缓和认知缺陷.
- DNAJC12现在是新生儿查的一部分,强调了基因诊断和早期干预的必要性.
研究的目的:
- 在患有致病性DNAJC12变异的患者中审查基因型-表型关系.
- 总结目前DNAJC12相关疾病的治疗模式.
- 提供DNAJC12蛋白质结构,变异及其在疾病中的作用的概述.
主要方法:
- 对DNA研究的文献综述JC12.
- 基因型-表型相关性的分析.
- 现有治疗策略的总结.
主要成果:
- 确定了DNAJC12变体的特定基因型-表型关系.
- 概述了当前和潜在的治疗方法.
- 详细介绍了DNAJC12的分子功能和疾病相关性.
结论:
- 对DNAJC12的早期分子测试至关重要,特别是对于未被诊断的成年人.
- 了解DNAJC12的作用有助于诊断和管理相关的神经疾病.
- 本综述为DNAJC12遗传学和治疗方法的从业者提供了全面的资源.
相关概念视频
Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
Human Genetics
586
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
586


